BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25420104)

  • 1. Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.
    Bird GH; Irimia A; Ofek G; Kwong PD; Wilson IA; Walensky LD
    Nat Struct Mol Biol; 2014 Dec; 21(12):1058-67. PubMed ID: 25420104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
    Guenaga J; Wyatt RT
    PLoS Pathog; 2012; 8(7):e1002806. PubMed ID: 22829767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
    Virology; 2017 May; 505():113-126. PubMed ID: 28237764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
    Cerutti N; Loredo-Varela JL; Caillat C; Weissenhorn W
    Curr Opin HIV AIDS; 2017 May; 12(3):250-256. PubMed ID: 28422789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
    Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
    J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.
    Li D; Liu J; Zhang L; Xu T; Chen J; Wang L; Zhao Q
    Virol Sin; 2015 Dec; 30(6):449-56. PubMed ID: 26715302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of membrane-bound fusion-peptide/MPER complexes by the HIV-1 neutralizing 2F5 antibody: implications for anti-2F5 immunogenicity.
    Huarte N; Araujo A; Arranz R; Lorizate M; Quendler H; Kunert R; Valpuesta JM; Nieva JL
    PLoS One; 2012; 7(12):e52740. PubMed ID: 23285173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface.
    Rujas E; Caaveiro JM; Partida-Hanon A; Gulzar N; Morante K; Apellániz B; García-Porras M; Bruix M; Tsumoto K; Scott JK; Jiménez MÁ; Nieva JL
    Sci Rep; 2016 Dec; 6():38177. PubMed ID: 27905530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
    Venditto VJ; Wieczorek L; Molnar S; Teque F; Landucci G; Watson DS; Forthal D; Polonis VR; Levy JA; Szoka FC
    Clin Vaccine Immunol; 2014 Aug; 21(8):1086-93. PubMed ID: 24872518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
    Wibmer CK; Gorman J; Ozorowski G; Bhiman JN; Sheward DJ; Elliott DH; Rouelle J; Smira A; Joyce MG; Ndabambi N; Druz A; Asokan M; Burton DR; Connors M; Abdool Karim SS; Mascola JR; Robinson JE; Ward AB; Williamson C; Kwong PD; Morris L; Moore PL
    PLoS Pathog; 2017 Jan; 13(1):e1006074. PubMed ID: 28076415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing Antibodies Targeting HIV-1 gp41.
    Caillat C; Guilligay D; Sulbaran G; Weissenhorn W
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33114242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
    J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.
    Montero M; Gulzar N; Klaric KA; Donald JE; Lepik C; Wu S; Tsai S; Julien JP; Hessell AJ; Wang S; Lu S; Burton DR; Pai EF; Degrado WF; Scott JK
    J Virol; 2012 Mar; 86(6):2930-41. PubMed ID: 22238313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies.
    Pejchal R; Gach JS; Brunel FM; Cardoso RM; Stanfield RL; Dawson PE; Burton DR; Zwick MB; Wilson IA
    J Virol; 2009 Sep; 83(17):8451-62. PubMed ID: 19515770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
    Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8.
    Sutar J; Padwal V; Sonawani A; Nagar V; Patil P; Kulkarni B; Hingankar N; Deshpande S; Idicula-Thomas S; Jagtap D; Bhattacharya J; Bandivdekar A; Patel V
    Virus Res; 2019 Nov; 273():197763. PubMed ID: 31553924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
    Soto C; Ofek G; Joyce MG; Zhang B; McKee K; Longo NS; Yang Y; Huang J; Parks R; Eudailey J; Lloyd KE; Alam SM; Haynes BF; ; Mullikin JC; Connors M; Mascola JR; Shapiro L; Kwong PD
    PLoS One; 2016; 11(6):e0157409. PubMed ID: 27299673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.